Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage Cell Therapeutics Inc

0.5200
+0.0000
Post-market: 0.52000.00000.00%19:51 EDT
Volume:875.50K
Turnover:461.14K
Market Cap:118.75M
PE:-5.59
High:0.5478
Open:0.5201
Low:0.5160
Close:0.5200
Loading ...

Lineage Cell (LCTX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks
·
31 Jan

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

THOMSON REUTERS
·
28 Jan

Lineage Cell Therapeutics Is Maintained at Buy by Maxim Group

Dow Jones
·
11 Jan

Maxim Group Keeps Their Buy Rating on Lineage Therap (LCTX)

TIPRANKS
·
10 Jan

Down -43.14% in 4 Weeks, Here's Why Lineage Cell (LCTX) Looks Ripe for a Turnaround

Zacks
·
17 Dec 2024

Is Lineage (LINE) the Best New Pick in Brad Gerstner’s Portfolio?

Insider Monkey
·
03 Dec 2024

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering

THOMSON REUTERS
·
22 Nov 2024

Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
21 Nov 2024

Lineage Cell Therapeutics tumbles after pricing $66M securities offering

seekingalpha
·
20 Nov 2024

BRIEF-Lineage Cell Therapeutics Announces Pricing Of Up To $66 Million Registered Direct Offering

Reuters
·
20 Nov 2024

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

THOMSON REUTERS
·
20 Nov 2024

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
19 Nov 2024

Lineage Cell Therapeutics Initiated at Buy by D. Boral Capital

Dow Jones
·
18 Nov 2024

Lineage Cell Therapeutics initiated with a Buy at D. Boral Capital

TIPRANKS
·
18 Nov 2024

Lineage Cell Therapeutics Inc (LCTX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
16 Nov 2024

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
15 Nov 2024